StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
81
Publishing Date
2023 - 04 - 27
90
2023 - 04 - 26
87
2023 - 04 - 18
81
2023 - 04 - 17
79
2023 - 02 - 23
83
2023 - 02 - 07
81
2023 - 01 - 09
96
2022 - 11 - 10
89
2022 - 11 - 03
93
2022 - 11 - 02
79
2022 - 11 - 01
101
2022 - 10 - 31
77
2022 - 08 - 11
88
2022 - 08 - 09
80
2022 - 08 - 04
104
2022 - 08 - 03
81
2022 - 08 - 02
83
2022 - 08 - 01
86
2022 - 07 - 28
80
2022 - 05 - 11
89
2022 - 05 - 10
89
2022 - 05 - 09
86
2022 - 05 - 05
81
2022 - 05 - 03
84
2022 - 05 - 02
88
2022 - 04 - 28
92
2022 - 04 - 27
81
2022 - 04 - 25
79
2022 - 03 - 03
87
2022 - 03 - 01
96
2022 - 02 - 28
86
2022 - 01 - 18
92
2022 - 01 - 06
78
2022 - 01 - 05
117
2022 - 01 - 04
131
2021 - 12 - 13
100
2021 - 11 - 11
90
2021 - 11 - 10
94
2021 - 11 - 09
94
2021 - 11 - 08
77
2021 - 11 - 04
127
2021 - 11 - 03
79
2021 - 10 - 28
88
2021 - 10 - 26
92
2021 - 10 - 07
75
2021 - 09 - 20
92
2021 - 09 - 09
91
2021 - 08 - 09
75
2021 - 08 - 05
91
2021 - 08 - 03
78
2021 - 05 - 17
76
2021 - 05 - 10
78
2021 - 05 - 05
81
2021 - 05 - 03
95
2021 - 04 - 27
89
2021 - 04 - 26
79
2021 - 04 - 20
92
2021 - 04 - 12
75
2021 - 03 - 15
87
2021 - 03 - 11
91
Sector
Commercial services
3
Consumer durables
1
Distribution services
1
Finance
3
Health services
6
Health technology
62
Manufacturing
1
Process industries
1
Producer manufacturing
2
Technology services
2
Tags
Acquired
2
Alliances
1
Anavex
1
Antibody
1
Application
1
Approval
1
Asia
2
Audio
1
Bio-nc
1
Biocanada
1
Biomidwest
3
Biopharma
1
Bioscience
1
Biotech
1
Biotech-bay
2
Biotech-beach
7
Biotechnology
5
Cancer
4
Ce mark
1
Ceo
1
Clinical trials
1
Clinical-trials-phase-i
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
1
Collaboration
1
Conference
21
Contract
1
Covid
4
Covid-19
2
Diagnostic
2
Drug
2
Earnings
9
Europe
2
Ev
3
Events
8
Eye
2
Fda
3
Financial results
22
Genetown
3
Genomic
3
Growth
2
Health
6
Iot
2
News
2
Opioid
2
People
3
Pharm-country
15
Presentation
5
Product-news
7
Report
2
Research
4
Results
29
Sales
2
Technology
3
Test
2
Therapeutics
5
Therapy
6
Treatment
2
Trial
4
Vaccine
2
Entities
3m company
1
Abbott laboratories
1
Adc therapeutics sa
1
Adma biologics inc
1
Aligos therapeutics, inc.
1
Amgen inc.
1
Amicus therapeutics, inc.
1
Anavex life sciences corp.
1
Annexon, inc.
1
Applied genetic technologies corporation
1
Astrazeneca plc
1
Baudax bio, inc.
1
Bausch health companies inc.
1
Beigene, ltd.
1
Biocept, inc.
1
Bristol-myers squibb company
1
Bruker corporation
1
Castle biosciences, inc.
1
Centogene n.v.
1
Clovis oncology, inc.
1
Cormedix inc.
1
Curis, inc.
1
Cyclacel pharmaceuticals, inc.
1
Diamedica therapeutics inc.
1
Editas medicine, inc.
2
Eli lilly and company
3
Establishment labs holdings inc.
1
Eyenovia, inc.
1
Fsd pharma inc.
1
Galera therapeutics, inc.
1
General motors company
1
Genprex, inc.
1
Gilead sciences, inc.
1
Hologic, inc.
1
Horizon therapeutics public limited company
1
Hoth therapeutics, inc.
1
Humanigen, inc.
1
Illinois tool works inc.
1
Incyte corporation
2
Infinity pharmaceuticals, inc.
1
Inmode ltd.
1
Intra-cellular therapies inc.
1
Ionis pharmaceuticals, inc.
1
Johnson & johnson
3
Kala pharmaceuticals, inc.
1
Kamada ltd.
1
Kintara therapeutics, inc.
1
Kymera therapeutics, inc.
1
Lensar, inc.
1
Lineage cell therapeutics, inc.
1
Longeveron llc - class a
1
Mannkind corporation
1
Mediwound ltd.
2
Merck & company, inc.
1
Metacrine, inc.
1
Morgan stanley
2
Navidea biopharmaceuticals, inc.
1
Nemaura medical inc.
1
Neogenomics, inc.
3
Sanofi
4
Symbols
ABT
1
ADCT
1
ADMA
1
AGTC
1
ALGS
1
AMGN
1
ANNX
1
AVXL
1
AZN
1
BGNE
1
BHC
1
BIOC
1
BMY
1
BRKR
1
BXRX
1
CLVS
1
CNTG
1
CRIS
1
CRMD
1
CSTL
1
CYCC
1
DMAC
1
EDIT
2
ESTA
1
EYEN
1
FOLD
1
GILD
1
GM
1
GNPX
1
GRTX
1
HGEN
1
HOLX
1
HOTH
1
HUGE
1
HZNP
1
INCY
2
INFI
1
INMD
1
IONS
1
ITCI
1
ITW
1
JNJ
3
KALA
1
KMDA
1
KTRA
1
KYMR
1
LCTX
1
LGVN
1
LLY
3
LNSR
1
MDWD
2
MITO
1
MMM
1
MNKD
1
MRK
1
MS
2
MTCR
1
NAVB
1
NEO
3
SNY
4
Exchanges
Amex
3
Nasdaq
67
Nyse
18
Crawled Date
2021 - 05 - 06
5
2021 - 05 - 05
76
Crawled Time
01:00
5
11:00
4
12:00
13
12:15
9
13:00
17
13:15
8
14:00
6
14:15
7
15:00
1
17:00
7
18:00
4
Source
beamforall.com
1
feed.businesswire.com
4
gflenv.com
1
investor.alkermes.com
1
investors.senseibio.com
1
ir.vtvtherapeutics.com
1
salariuspharma.com
1
www.admabiologics.com
1
www.adnas.com
1
www.akerotx.com
1
www.allegiancebank.com
1
www.amcnetworks.com
2
www.ameresco.com
1
www.ampiopharma.com
1
www.anaplan.com
1
www.aravive.com
1
www.biospace.com
81
www.bktechnologies.com
1
www.blackknightinc.com
1
www.blinkcharging.com
1
www.canterburypark.com
2
www.cardlytics.com
1
www.chiasmapharma.com
1
www.cleanenergyfuels.com
1
www.cvdequipment.com
1
www.dukerealty.com
2
www.extremenetworks.com
2
www.ezcorp.com
1
www.fda.gov
1
www.genesisenergy.com
3
www.globenewswire.com
147
www.greenlightre.ky
1
www.heritagepci.com
1
www.hormelfoods.com
1
www.hubspot.com
5
www.hudsontech.com
1
www.keytronic.com
1
www.kopin.com
2
www.lhcgroup.com
1
www.mreic.com
2
www.myomo.com
1
www.nanthealth.com
2
www.nexstar.tv
1
www.northropgrumman.com
1
www.ooma.com
3
www.phreesia.com
1
www.postalrealtytrust.com
1
www.preit.com
1
www.prnewswire.com
193
www.purecyclewater.com
1
www.quotient.com
1
www.repay.com
1
www.rgcresources.com
1
www.riministreet.com
1
www.santanderconsumerusa.com
1
www.sempra.com
1
www.smithmicro.com
1
www.snowflake.com
1
www.sutrobio.com
1
www.tasekomines.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
publishing date :
2021 - 05 - 05
source :
Www.biospace.com
save search
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results
Published:
2021-05-05
(Crawled : 01:00)
- biospace.com/
DMAC
|
News
|
$2.58
8.86%
8.14%
41K
|
Health Technology
|
-74.0%
|
O:
1.26%
H:
0.0%
C:
-2.07%
financial results
results
Stealth BioTherapeutics Showcases Data for Elamipretide in Dry Age-Related Macular Degeneration at the 2021 ARVO Annual Meeting
Published:
2021-05-05
(Crawled : 01:00)
- biospace.com/
MITO
|
$0.32
0.25%
|
Health Technology
|
-73.55%
|
O:
0.0%
H:
1.65%
C:
-0.83%
iot
macular
elamipretide
ADC Therapeutics’ ZYNLONTA™ (loncastuximab tesirine-lpyl) Added to National Comprehensive Cancer Network® Clinical Practice Guidelines in Oncology for B-cell Lymphomas
Published:
2021-05-05
(Crawled : 01:00)
- biospace.com/
ADCT
|
$4.96
11.71%
1.41%
1.2M
|
Health Technology
|
-80.31%
|
O:
-0.67%
H:
2.95%
C:
-1.79%
cancer
t-cell
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Combined With Trastuzumab and Chemotherapy as First-line Treatment in Locally Advanced Unresectable or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma
Published:
2021-05-05
(Crawled : 01:00)
- biospace.com/
MRK
|
$125.37
0.25%
0.1%
6.1M
|
Health Technology
|
64.98%
|
O:
0.14%
H:
2.14%
C:
2.1%
treatment
fda
positive
therapy
fda approval
her2+
keytruda
her2-
her2
New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant
Published:
2021-05-05
(Crawled : 01:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-97.85%
|
O:
3.47%
H:
4.31%
C:
-8.13%
covid
phase 2
results
vaccine
phase 2b
trial
trial results
CENTOGENE Discovers Six New Rare Diseases by Leveraging the Strength of Its Bio/DatabankResearch leads to diagnosis and treatment options for rare disease patients
Published:
2021-05-05
(Crawled : 18:00)
- biospace.com/
CNTG
|
$0.4801
0.14%
17K
|
Commercial Services
|
-95.15%
|
O:
1.11%
H:
4.4%
C:
-2.5%
disease
treatment
research
rare
diagnostic
United Therapeutics Corporation Reports First Quarter 2021 Financial Results
Published:
2021-05-05
(Crawled : 18:00)
- biospace.com/
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
298.92%
|
O:
0.24%
H:
2.61%
C:
2.21%
UTHR
|
$235.44
1.58%
1.55%
370K
|
Health Technology
|
20.44%
|
O:
0.0%
H:
3.21%
C:
1.42%
financial results
results
therapeutics
Xilio Therapeutics Appoints Christina Rossi to Its Board of Directors
Published:
2021-05-05
(Crawled : 18:00)
- biospace.com/
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-8.55%
|
O:
0.1%
H:
0.59%
C:
0.22%
therapeutics
Clinical News: MDMA and Therapy Significantly Benefits PTSD Patients and More
Published:
2021-05-05
(Crawled : 18:00)
- biospace.com/
VERU
|
$1.165
-7.17%
-7.73%
2.5M
|
Health Technology
|
-86.67%
|
O:
20.23%
H:
6.88%
C:
-15.97%
therapy
Lilly to Participate in Bank of America Securities 2021 Health Care Conference
Published:
2021-05-05
(Crawled : 17:00)
- biospace.com/
LLY
|
News
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
298.92%
|
O:
0.24%
H:
2.61%
C:
2.21%
conference
health
Longeveron Invited to Present at the Benzinga Global Small Cap Conference
Published:
2021-05-05
(Crawled : 17:00)
- biospace.com/
LGVN
|
News
P
6 d
|
$2.08
-41.08%
-69.71%
3.3M
|
|
-64.76%
|
O:
-0.51%
H:
3.47%
C:
-0.17%
conference
Scandal Watch: Elizabeth Holmes Appears in Court, Opioid Distributors on Tria...
Published:
2021-05-05
(Crawled : 17:00)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-13.71%
|
O:
-0.16%
H:
0.0%
C:
-0.26%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-34.94%
|
O:
0.9%
H:
1.68%
C:
-0.59%
opioid
Humanigen Announces Publication of Results From Phase 3 Randomized Double-Blind Placebo-Controlled Study Demonstrating the Efficacy and Safety of Lenzilumab™ in Hospitalized COVID-19 Patients
Published:
2021-05-05
(Crawled : 17:00)
- biospace.com/
HGEN
|
$0.0361
-61.5%
120M
|
Health Technology
|
-99.8%
|
O:
-1.0%
H:
12.15%
C:
6.49%
covid
results
lenzilumab
phase 3
Genprex Announces Centralized Institutional Review Board Approval for Acclaim-1 Clinical Trial in Non-Small Cell Lung Cancer
Published:
2021-05-05
(Crawled : 17:00)
- biospace.com/
GNPX
|
$2.26
-1.74%
-1.77%
21K
|
Health Technology
|
-39.95%
|
O:
0.54%
H:
3.11%
C:
-1.89%
lung cancer
cancer
trial
approval
Wipro Partners with Transcell Oncologics to Transform Vaccine Safety Assessment
Published:
2021-05-05
(Crawled : 17:00)
- biospace.com/
WIT
|
$5.25
-0.19%
0.1%
2.2M
|
Technology Services
|
-26.37%
|
O:
2.52%
H:
0.0%
C:
-0.96%
vaccine
Scandal Watch: Elizabeth Holmes Appears in Court, Opioid Distributors on Trial and More
Published:
2021-05-05
(Crawled : 17:00)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-13.71%
|
O:
-0.16%
H:
0.0%
C:
-0.26%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-34.94%
|
O:
0.9%
H:
1.68%
C:
-0.59%
opioid
trial
MannKind Corporation to Hold 2021 First Quarter Financial Results Conference Call on May 12, 2021
Published:
2021-05-05
(Crawled : 15:00)
- biospace.com/
MNKD
|
$4.105
1.36%
1.34%
2.3M
|
Health Technology
|
-5.09%
|
O:
1.16%
H:
0.47%
C:
-4.81%
financial results
results
conference
MediWound Reports First Quarter 2021 Financial Results
Published:
2021-05-05
(Crawled : 14:15)
- biospace.com/
MDWD
|
$17.395
-4.84%
-5.09%
160K
|
Health Technology
|
272.65%
|
O:
1.71%
H:
0.42%
C:
-11.13%
financial results
results
report
Hoth Therapeutics and Virginia Commonwealth University Expand Research Agreement for COVID-19 Therapeutic
Published:
2021-05-05
(Crawled : 14:15)
- biospace.com/
HOTH
|
$1.19
-0.83%
-0.84%
24K
|
Health Technology
|
-13.38%
|
O:
6.34%
H:
0.66%
C:
0.0%
covid
research
therapeutics
covid-19
Carmine Therapeutics appoints Don Haut as CEO
Published:
2021-05-05
(Crawled : 14:15)
- biospace.com/
MMM
|
$90.96
-0.1%
0.0%
3.4M
|
Producer Manufacturing
|
-54.38%
|
O:
0.31%
H:
0.86%
C:
0.72%
ceo
leo
therapeutics
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.